Hat Tip: Aniruddha Jain
Around 5 months back,CLSA came out with a “Sell” recommendation on Biocon which led to a very public Twitter fight between the Biocon CEO and an analyst.
Biocon was trading around Rs.534 when CLSA issued the Sell Recommendation.
Its trading around Rs.723 today,up by almost 35% in the space of 5 months.
Forecasting Folly,anyone?
4 replies on “Forecasting Folly:CLSA Edition”
Normally love your forecasting follies – but this is too short a time frame to judge.
PS: I have no views on Biocon and completely neutral.
Yes…put it up because Biocon is near its all time highs
I believed in their syn-gen listing and bought at 438 per share 50 share and sitting in profit . Commonsense needed it is no rocket science
It is up, could because of trading and 35% is not high enough to confirm anything. In my opinion biocon is yet to prove. Two years down the line there is possibility that this post could come in forecast folly 🙂